Suzanne M. Hess

495 total citations
21 papers, 393 citations indexed

About

Suzanne M. Hess is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Suzanne M. Hess has authored 21 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Suzanne M. Hess's work include Metal complexes synthesis and properties (4 papers), Cancer-related Molecular Pathways (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Suzanne M. Hess is often cited by papers focused on Metal complexes synthesis and properties (4 papers), Cancer-related Molecular Pathways (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Suzanne M. Hess collaborates with scholars based in United States, Australia and France. Suzanne M. Hess's co-authors include Thea D. Tlsty, Ulrich Bierbach, Joel G. Anderson, Joel E. Tepper, A. William Blackstock, Steven A. Leadon, Kenneth Aldape, Janice Nigro, Beverly S. Mitchell and Mary L. Hixon and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Blood.

In The Last Decade

Suzanne M. Hess

20 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suzanne M. Hess United States	11	238	227	66	66	33	21	393
M Li Canada	5	296 1.2×	196 0.9×	25 0.4×	66 1.0×	40 1.2×	7	451
Steven M. Schmid United States	11	194 0.8×	132 0.6×	64 1.0×	35 0.5×	39 1.2×	14	389
Carmen Plasencia United States	9	313 1.3×	227 1.0×	88 1.3×	81 1.2×	40 1.2×	12	547
Augustin Le Naour France	9	146 0.6×	127 0.6×	97 1.5×	61 0.9×	31 0.9×	12	394
Aiping Young Canada	14	311 1.3×	181 0.8×	157 2.4×	77 1.2×	29 0.9×	26	712
Serban San‐Marina Canada	9	224 0.9×	122 0.5×	27 0.4×	48 0.7×	43 1.3×	20	385
Yasutaka Takeda Japan	10	119 0.5×	187 0.8×	32 0.5×	48 0.7×	12 0.4×	30	371
Yanbo Zheng China	11	169 0.7×	86 0.4×	35 0.5×	69 1.0×	56 1.7×	40	308
R. Faissner Germany	10	115 0.5×	232 1.0×	31 0.5×	63 1.0×	30 0.9×	16	365
Brenda J. Foster United States	12	293 1.2×	143 0.6×	84 1.3×	33 0.5×	54 1.6×	15	476

Countries citing papers authored by Suzanne M. Hess

Since Specialization

Citations

This map shows the geographic impact of Suzanne M. Hess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne M. Hess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne M. Hess more than expected).

Fields of papers citing papers by Suzanne M. Hess

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne M. Hess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne M. Hess. The network helps show where Suzanne M. Hess may publish in the future.

Co-authorship network of co-authors of Suzanne M. Hess

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne M. Hess. A scholar is included among the top collaborators of Suzanne M. Hess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne M. Hess. Suzanne M. Hess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zsíros, Emese, Anzer Khan, Thejaswini Giridharan, et al.. (2025). Effects of complement C3/C3b inhibition on control of malignant effusions and neutrophil phenotypes in patients with recurrent epithelial ovarian cancer: Interim analysis of a phase 2 clinical trial. Immunobiology. 230(4). 152995–152995. 1 indexed citations

Hess, Suzanne M., et al.. (2025). Tertiary lymphoid structures: exploring opportunities to improve immunotherapy in ovarian cancer. Frontiers in Immunology. 16. 1473969–1473969. 1 indexed citations

Gaulin, Nicole, Gabriel Silva Santos, Suzanne M. Hess, et al.. (2025). BiTE-secreting T cells rationally combine with PD-1 blockade and vaccine boosting to reshape antitumor immunity in ovarian cancer. Molecular Therapy. 34(1). 455–478.

Rosario, Spencer R., Mark D. Long, Shanmuga Reddy Chilakapati, et al.. (2024). Integrative multi-omics analysis uncovers tumor-immune-gut axis influencing immunotherapy outcomes in ovarian cancer. Nature Communications. 15(1). 10609–10609. 10 indexed citations

McGray, AJ Robert, Takemasa Tsuji, Mark D. Long, et al.. (2023). BiTE secretion by adoptively transferred stem-like T cells improves FRα+ ovarian cancer control. Journal for ImmunoTherapy of Cancer. 11(6). e006863–e006863. 6 indexed citations

Daneshmandi, Saeed, Cameron R. MacDonald, Manu Pandey, et al.. (2022). β2-AR Signaling Enhances MDSC Survival through Metabolic Reprograming and Impairs Therapeutic Efficacy in Hematologic Malignancies. Blood. 140(Supplement 1). 8867–8869. 1 indexed citations

Glaser, Kathryn, et al.. (2019). Implementing an Integrative Survivorship Program at a Comprehensive Cancer Center: A Multimodal Approach to Life After Cancer. The Journal of Alternative and Complementary Medicine. 25(S1). S106–S111. 14 indexed citations

Hess, Suzanne M., et al.. (2005). The in vitro cytotoxic and radiation sensitizing effects of docetaxel (Taxotere) and a novel taxane RPR116258 on Glioblastoma cell lines. Cancer Research. 65. 341–341. 1 indexed citations

Hess, Suzanne M., et al.. (2005). Platinum-acridinylthiourea conjugates show cell line-specific cytotoxic enhancement in H460 lung carcinoma cells compared to cisplatin. Cancer Chemotherapy and Pharmacology. 56(4). 337–343. 19 indexed citations

10.

Hess, Suzanne M., Joel G. Anderson, & Ulrich Bierbach. (2004). A non-crosslinking platinum–acridine hybrid agent shows enhanced cytotoxicity compared to clinical BCNU and cisplatin in glioblastoma cells. Bioorganic & Medicinal Chemistry Letters. 15(2). 443–446. 20 indexed citations

11.

Barry, Colin G., Cynthia S. Day, Marcus W. Wright, et al.. (2004). Structure–activity relationships in platinum–acridinylthiourea conjugates: effect of the thiourea nonleaving group on drug stability, nucleobase affinity, and in vitro cytotoxicity. JBIC Journal of Biological Inorganic Chemistry. 9(4). 453–461. 42 indexed citations

12.

Block, Keith I., et al.. (2004). Point-Counterpoint: Using Clinical Trials for the Evaluation of Integrative Cancer Therapies. Integrative Cancer Therapies. 3(1). 66–81. 7 indexed citations

13.

Anderson, Joel G., et al.. (2003). Bis(acridinylthiourea)platinum(II) complexes: synthesis, DNA affinity, and biological activity in glioblastoma cells. Bioorganic & Medicinal Chemistry Letters. 13(5). 855–858. 20 indexed citations

14.

Blackstock, A. William, L. D. Case, Joel E. Tepper, et al.. (2001). Tumor uptake and elimination of 2',2'-difluoro-2'-deoxycytidine (gemcitabine) after deoxycytidine kinase gene transfer: correlation with in vivo tumor response.. PubMed. 7(10). 3263–8. 64 indexed citations

15.

Cipriani, Joseph, et al.. (2000). Collaboration in the Therapeutic Process. Physical & Occupational Therapy In Geriatrics. 17(1). 43–54. 3 indexed citations

16.

Hess, Suzanne M., et al.. (1999). Human mammary epithelial cells exhibit a differential p53-mediated response following exposure to ionizing radiation or UV light. Oncogene. 18(42). 5795–5805. 33 indexed citations

17.

Nigro, Janice, Kenneth Aldape, Suzanne M. Hess, & Thea D. Tlsty. (1997). Cellular adhesion regulates p53 protein levels in primary human keratinocytes.. PubMed. 57(17). 3635–9. 39 indexed citations

18.

Blackstock, A. William, Lester Kwock, Suzanne M. Hess, Steven A. Leadon, & Joel E. Tepper. (1997). 141 Gemcitabine: In vitro and in vivo evidence of its radiation sensitizing activity and studies using fluorine-19 magnetic resonance spectroscopy to determine an optimal gemcitabine dosing schedule - pre-clinical observations relevant to gemcitabine clinical trials. International Journal of Radiation Oncology*Biology*Physics. 39(2). 205–205. 18 indexed citations

19.

Tlsty, Thea D., Antonio Gualberto, Ingrid J. Hall, et al.. (1995). Genomic instability and cancer. Mutation Research/DNA Repair. 337(1). 1–7. 77 indexed citations

20.

Hess, Suzanne M., David R. Stanford, & Anita K. Hopper. (1994). SRD1, aS.cerevisiaegene affecting pre-rRNA processing contains a C₂/C₂zinc finger motif. Nucleic Acids Research. 22(7). 1265–1271. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact